Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1

Status

Completed 6Unknown 2Active not recruiting 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Prostatic Neoplasms 2Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Recurrence 1Polycystic Ovary Syndrome 1Obesity 1Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Brain Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Glucocorticoids × Clear all
NCT04042220 2024-01-05

Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases

Medical University of Vienna

Completed
200 enrolled
CNS

Brain Neoplasms

NCT01576588 2019-12-27

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Vilnius University

Phase 2 Completed
25 enrolled 9 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00805207 2018-08-01

SCOR

Washington University School of Medicine

Phase NA Completed
61 enrolled 17 charts
Other

Obesity, Polycystic Ovary Syndrome, Sleep Apnea Syndromes, Sleep Apnea, Obstructive

NCT00201812 2017-12-06

Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
27 enrolled
Tumor-Agnostic

Neoplasms

NCT00474383 2014-05-12

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Cougar Biotechnology, Inc.

Phase 2 Completed
47 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT01664728 2013-04-19

An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001

Janssen Research & Development, LLC

Phase 1 Completed
54 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡